 |
The Journal of Neuroscience, July 26, 2006, 26(30):7974-7983; doi:10.1523/JNEUROSCI.0897-06.2006
Previous Article | Next Article 
Neurobiology of Disease
Mitochondrial Translocation of p53 Mediates Release of Cytochrome c and Hippocampal CA1 Neuronal Death after Transient Global Cerebral Ischemia in Rats
Hidenori Endo,
Hiroshi Kamada,
Chikako Nito,
Tatsuro Nishi, and
Pak H. Chan
Department of Neurosurgery, Department of Neurology and Neurological Sciences, and Program in Neurosciences, Stanford University School of Medicine, Stanford, California 94305-5487
Correspondence should be addressed to Dr. Pak H. Chan, Neurosurgical Laboratories, Stanford University, 1201 Welch Road, MSLS #P314, Stanford, CA 94305-5487. phchan{at}stanford.edu
Although p53 is a key modulator of cellular stress responses, the mechanism of p53-mediated apoptosis is ambiguous. p53 can mediate apoptosis in response to death stimuli by transcriptional activation of proapoptotic genes and transcriptional-independent mechanisms. Recent studies have shown that the p53 protein can directly induce permeabilization of the outer mitochondrial membrane by forming a inhibitory complex with a protective Bcl-2 family protein, resulting in cytochrome c release. However, how the mitochondrial p53 pathway mediates neuronal apoptosis after cerebral ischemia remains unclear. We examined the interaction between the mitochondrial p53 pathway and vulnerable hippocampal CA1 neurons in rats using a transient global cerebral ischemia (tGCI) model. Western blot analysis and immunofluorescent staining revealed mitochondrial p53 translocation after tGCI in the hippocampal CA1 neurons. Coimmunoprecipitation revealed that translocated p53 bound to Bcl-XL in the mitochondrial fraction. To examine the effect of a specific p53 inhibitor on the mitochondrial p53 pathway and apoptotic cell death after tGCI, we intravenously administered pifithrin- (PFT). Mitochondrial p53 translocation and interaction between p53 and Bcl-XL were prevented by treatment with PFT. Moreover, cytochrome c release from mitochondria and subsequent apoptotic CA1 neuronal death were decreased with PFT treatment. These results suggest that the mitochondrial p53 pathway is one of the novel mechanisms mediating delayed death of vulnerable hippocampal CA1 neurons after tGCI.
Key words: p53; mitochondrial translocation; global cerebral ischemia; apoptosis; hippocampal CA1 neurons; rat
Received Nov. 28, 2005;
revised May 12, 2006;
accepted June 8, 2006.
Correspondence should be addressed to Dr. Pak H. Chan, Neurosurgical Laboratories, Stanford University, 1201 Welch Road, MSLS #P314, Stanford, CA 94305-5487. phchan{at}stanford.edu
This article has been cited by other articles:

|
 |

|
 |
 
B. R.S. Broughton, D. C. Reutens, and C. G. Sobey
Apoptotic Mechanisms After Cerebral Ischemia
Stroke,
May 1, 2009;
40(5):
e331 - e339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Niizuma, H. Endo, C. Nito, D. J. Myer, and P. H. Chan
Potential Role of PUMA in Delayed Death of Hippocampal CA1 Neurons After Transient Global Cerebral Ischemia
Stroke,
February 1, 2009;
40(2):
618 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Kruse and W. Gu
MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
J. Biol. Chem.,
January 30, 2009;
284(5):
3250 - 3263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H.A. Nijboer, C. J. Heijnen, F. Groenendaal, M. J. May, F. van Bel, and A. Kavelaars
Strong Neuroprotection by Inhibition of NF-{kappa}B After Neonatal Hypoxia-Ischemia Involves Apoptotic Mechanisms but Is Independent of Cytokines
Stroke,
July 1, 2008;
39(7):
2129 - 2137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uo, Y. Kinoshita, and R. S. Morrison
Apoptotic Actions of p53 Require Transcriptional Activation of PUMA and Do Not Involve a Direct Mitochondrial/Cytoplasmic Site of Action in Postnatal Cortical Neurons
J. Neurosci.,
November 7, 2007;
27(45):
12198 - 12210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Perier, J. Bove, D.-C. Wu, B. Dehay, D.-K. Choi, V. Jackson-Lewis, S. Rathke-Hartlieb, P. Bouillet, A. Strasser, J. B. Schulz, et al.
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease
PNAS,
May 8, 2007;
104(19):
8161 - 8166.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|